Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

222 та иш

Иш: Interactions and communications in the glioblastoma microenvironment: potential targets for chemo-/radiotherapy

  1. Abscopal effect in radioimmunotherapy

    Milad Ashrafizadeh, Bagher Farhood, Ahmed Eleojo Musa +3

    Шарҳ мақола20207 иқтибос
    ABI

  2. The interactions and communications in tumor resistance to radiotherapy: Therapy perspectives

    Milad Ashrafizadeh, Bagher Farhood, Ahmed Eleojo Musa +2

    Шарҳ мақола20207 иқтибос
    ABI

  3. Targeting of the tumor immune microenvironment by metformin

    Zihong Wu, Caidie Zhang, Masoud Najafi

    Шарҳ мақола20215 иқтибос
    ABI

  4. NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma

    Tobias Weiß, Michael Weller, Matthias Gückenberger +2

    Мақола20173 иқтибос
    ABI

  5. The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment

    Vinit Kumar, Sima Patel, Evgenii N. Tcyganov +1

    Шарҳ мақола20163 иқтибос
    ABI

  6. Mechanisms of immunotherapy resistance: lessons from glioblastoma

    Christopher M. Jackson, John Choi, Michael Lim

    Шарҳ мақола20192 иқтибос
    ABI

  7. Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial

    Stephen Bagley, Zev A. Binder, Lamia Lamrani +32

    Мақола20242 иқтибос
    ABI

  8. Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results

    Stephen Bagley, Meghan Logun, Joseph A. Fraietta +30

    Мақола20242 иқтибос
    ABI

  9. Anti-PD-1/Anti-PD-L1 Drugs and Radiation Therapy: Combinations and Optimization Strategies

    Jihane Boustani, Benoît Lecoester, Jérémy Baude +4

    Шарҳ мақола20212 иқтибос
    ABI

  10. Normalizing Tumor Vasculature to Reduce Hypoxia, Enhance Perfusion, and Optimize Therapy Uptake

    Kathy Matuszewska, Madison Pereira, Duncan Petrik +2

    Шарҳ мақола20212 иқтибос
    ABI

  11. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

    Roger Stupp, Monika E. Hegi, Warren Mason +21

    Мақола20092 иқтибос
    ABI

  12. IGF-1-enhanced miR-513a-5p signaling desensitizes glioma cells to temozolomide by targeting the NEDD4L-inhibited Wnt/β-catenin pathway

    Ku‐Chung Chen, Peng-Hsu Chen, Kuo-Hao Ho +4

    Мақола20192 иқтибос
    ABI

  13. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

    Michael Weller, Martin J. van den Bent, Matthias Preusser +21

    Шарҳ мақола20202 иқтибос
    ABI

  14. Polymorphonuclear-MDSCs Facilitate Tumor Regrowth After Radiation by Suppressing CD8+ T Cells

    Jieying Zhang, Liling Zhang, Yuhui Yang +7

    Мақола20202 иқтибос
    ABI

  15. Hypoxia Potentiates Glioma-Mediated Immunosuppression

    Jun Wei, Adam Wu, Ling Yuan Kong +6

    Мақола20112 иқтибос
    ABI

  16. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment

    Qianghu Wang, Baoli Hu, Xin Hu +31

    Мақола20172 иқтибос
    ABI

  17. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  18. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  19. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  20. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  21. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  22. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  23. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  24. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  25. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI